The rapid development of vaccines against COVID-19 should be a positive, life-saving development. Happening at a speed many in the medical field would have previously thought impossible, these vaccines provide a glimmer of hope that an end to this once-in-a-century pandemic is possible. But instead of national governments and pharmaceutical companies cooperating to vaccinate the world’s population as quickly as possible, other priorities are informing the distribution of vaccines.
  • Muad'DibberM
    5•3 years ago

    But these spats amongst wealthy countries are only one part of the problem, and are likely to abate once production increases. A report from the Intelligence Unit at the Economist predicts that most of Europe, the UK and US will have widespread vaccination coverage by the end of 2021, with the remainder of the advanced economies likely to have coverage by mid-2022.

    For the countries that cannot afford to pay, it is a different story. “[W]idespread vaccination coverage will not be achieved before 2023, if it happens at all” is the likely scenario for developing countries, according to the report.

    This is because COVID-19 vaccines, and the companies competing to make them, are not charitable endeavours. The aim is to make money by selling to those who can pay. The vaccine industry pre-COVID was already estimated to be worth US$35 billion, and it will get a welcome boost from COVID-19. Pfizer alone is expected to make US$15 billion this year from its vaccine. To maximise these profits, supplies will go to the highest bidders.

    So fucked that poorer countries aren’t getting vaccinated until 2 years after the rich countries are.